Trials / Sponsors / ImmuneOncia Therapeutics Inc.
ImmuneOncia Therapeutics Inc.
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor TMB-H, Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors | Phase 2 | 2025-01-13 |
| Recruiting | A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy Advanced Cancer | Phase 1 | 2022-06-02 |
| Active Not Recruiting | A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type Extranodal NK/T-cell Lymphoma, Nasal Type, Extranodal NK/T-cell Lymphoma | Phase 2 | 2020-10-27 |
| Completed | A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lym Solid Tumor, Lymphoma | Phase 1 | 2020-06-05 |
| Completed | Dose-escalation Study of IMC-001 in Subject With Metastatic or Locally-advanced Solid Tumors Solid Tumor, Metastasis, Locally Advanced | Phase 1 | 2018-03-22 |